CIK 0001100682 · Large accelerated filer
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Sign in to watch- Ticker
- CRL
- Exchange
- NYSE
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 27
- Entity type
- operating
- EIN
- 061397316
- Phone
- 781-222-6000
- Business address
- 251 BALLARDVALE ST, WILMINGTON, MA, 01887
- Former names
- CHARLES RIVER LABORATORIES INTERNATIONAL INC, CHARLES RIVER LABORATORIES HOLDINGS INC
- Open-market buys, last 90 days
- $2,974
- in 1 filing
- Open-market sales, last 90 days
- $20,291,281
- in 6 filings, $20.1M under 10b5-1 plans
Net −$20,288,307. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-15 | MASSARO GEORGE Director | Sale 10b5-1 | −113 | $235.61 | $27K | 5,951 |
| 2024-05-15 | MASSARO GEORGE Director | Sale 10b5-1 | −96 | $236.78 | $23K | 5,855 |
| 2024-05-13 | WILSON VIRGINIA M Director | Grant or award | +559 | $228.41 | $128K | 3,965 |
| 2024-05-13 | WILSON VIRGINIA M Director | Grant or award · Stock Options (Right to Buy) | +1,311 | $228.41 | $299K | 1,311 |
| 2024-05-13 | Andrews Nancy C Director | Grant or award | +559 | $228.41 | $128K | 3,018 |
| 2024-05-13 | Andrews Nancy C Director | Grant or award · Stock Options (Right to Buy) | +1,311 | $228.41 | $299K | 1,311 |
| 2024-05-13 | MACKAY MARTIN Director | Grant or award | +559 | $228.41 | $128K | 12,159 |
| 2024-05-13 | MACKAY MARTIN Director | Grant or award | +372 | $228.41 | $85K | 12,531 |
| 2024-05-13 | MACKAY MARTIN Director | Grant or award · Stock Options (Right to Buy) | +1,311 | $228.41 | $299K | 1,311 |
| 2024-05-13 | Thompson Craig B. Director | Grant or award | +559 | $228.41 | $128K | 1,467 |
| 2024-05-13 | Thompson Craig B. Director | Grant or award · Stock Options (Right to Buy) | +1,311 | $228.41 | $299K | 1,311 |
| 2024-05-13 | WALLMAN RICHARD F Director | Grant or award | +559 | $228.41 | $128K | 23,087 |
| 2024-05-13 | WALLMAN RICHARD F Director | Grant or award | +460 | $228.41 | $105K | 23,547 |
| 2024-05-13 | WALLMAN RICHARD F Director | Grant or award · Stock Options (Right to Buy) | +1,311 | $228.41 | $299K | 1,311 |
| 2024-05-13 | BERTOLINI ROBERT J Director | Grant or award | +559 | $228.41 | $128K | 32,408 |
| 2024-05-13 | BERTOLINI ROBERT J Director | Grant or award | +394 | $228.41 | $90K | 32,802 |
| 2024-05-13 | BERTOLINI ROBERT J Director | Grant or award · Stock Options (Right to Buy) | +1,311 | $228.41 | $299K | 1,311 |
| 2024-05-13 | Kemps-Polanco Reshema Director | Grant or award | +559 | $228.41 | $128K | 729 |
| 2024-05-13 | Kemps-Polanco Reshema Director | Grant or award | +285 | $228.41 | $65K | 1,014 |
| 2024-05-13 | Kemps-Polanco Reshema Director | Grant or award · Stock Options (Right to Buy) | +1,311 | $228.41 | $299K | 1,311 |
Page 15 of 41 · 819 trades